Global shares ended mostly on a down note - Thursday Review, November 19

By: Miguel A. Rodriguez

11:05, 20 November 2020

The American benchmarks reversed losses amid talks about a new stimulus package

The US

The rising number of COVID-19 infections seems to have put the stimulus package back on the table. The benchmarks reacted positively to the news, leaving behind the high number of unemployment claims. USA30 went up 0.18%, while USA500 rose 0.36%. TECH100 gained 0.87%.

Crude oil traded 0.8% lower at $41.66 per barrel.

Gold fell 1% to $1,855 per ounce.

The Dollar Index closed at 92.575.


Asia and Australia

The news regarding AstraZeneca’s vaccine was overshadowed by the new restrictions meant to curb the COVID-19 infections.

HongKong45 fell 0.77%.

Japan225 lost 0.77%.

Down under, Australia200 closed 0.17% lower.



Despite AstraZeneca's positive data regarding its experimental COVID-19 vaccine, the markets ended in the red. Germany30 and UK100 each traded 0.9% lower. France40 lost 0.8%.

Brent oil inched 0.5% lower to $44.11 a barrel.

EUR/USD traded at 1.1831 after losing 0.2%.


Share this article

This information prepared by is not an offer or a solicitation for the purpose of purchase or sale of any financial products referred to herein or to enter into any legal relations, nor an advice or a recommendation with respect to such financial products.This information is prepared for general circulation. It does not regard to the specific investment objectives, financial situation, or the particular needs of any recipient.You should independently evaluate each financial product and consider the suitability of such a financial product, by taking into account your specific investment objectives, financial situation, or particular needs, and by consulting an independent financial adviser as needed, before dealing in any financial products mentioned in this document.This information may not be published, circulated, reproduced, or distributed in whole or in part to any other person without the Company’s prior written consent.
Past performance is not always indicative of likely or future performance. Any views or opinions presented are solely those of the author and do not necessarily represent those of Financial Services (Pty) Ltd trading as CAPEX.COM/ZA acts as intermediary between the investor and Magnasale Trading Ltd, the counterparty to the contract for difference purchased by the Investor via CAPEX.COM/ZA, authorised & regulated by the Cyprus Securities and Exchange Commission with license number 264/15.  Magnasale Trading Ltd is the principal to the CFD purchased by investors.